CBLI - Cleveland BioLabs, Inc. Summary, Stock Quote and News | Benzinga

Skip to main content

Market Overview

4.920 -0.02 (-0.4%)

Data as of May 18, 2021

Prev. Close 4.94
Price Open 4.9
Volume 45,321
Day's Range 4.87 - 5.2699
52 Wk Range 1.43 - 10.9718
50 Day Moving Avg. 5.6
PE Ratio
Shares Outstanding 15.47M
Market Cap 76.11M

Trade CBLI stock for free with recommended broker TD Ameritrade.

Analyst Rating View All Ratings

Cleveland BioLabs shares are trading lower. Not seeing company-specific news from the session. Bill HaddadWed, 12 May 2021 15:36:35 -0400
48 Biggest Movers From Yesterday Lisa LevinThu, 15 Apr 2021 05:58:20 -0400
30 Stocks Moving In Wednesday's Mid-Day Session Lisa LevinWed, 14 Apr 2021 12:09:23 -0400
Cleveland BioLabs Joint Venture Genome Protection Highlights Publication Of TLR5 Agonist, GP532 In Communications Biology Bill HaddadWed, 14 Apr 2021 08:13:13 -0400
50 Biggest Movers From Yesterday Lisa LevinWed, 14 Apr 2021 04:58:58 -0400
80 Biggest Movers From Friday Lisa LevinMon, 22 Feb 2021 05:59:48 -0400
Cleveland BioLabs shares are trading lower after the company announced $14 million registered direct offering of common stock. The offering is priced at $7 per share. Zoltan SuranyiFri, 19 Feb 2021 16:45:01 -0400
Cleveland BioLabs Shares Halted On Circuit Breaker; Co Announces $14M Registered Direct Offering Of 2M Shares Of Common Stock At $7/Share Benzinga NewsdeskFri, 19 Feb 2021 14:32:52 -0400
12 Health Care Stocks Moving In Friday's Intraday Session Benzinga InsightsFri, 19 Feb 2021 13:47:30 -0400
12 Health Care Stocks Moving In Friday's Pre-Market Session Benzinga InsightsFri, 19 Feb 2021 09:08:18 -0400
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Genome Protection Announces Publication of the Next Generation Deimmunized TLR5 Agonist, GP532 ACCESSWIREApr 14, 2021
SHAREHOLDER ALERT: WeissLaw LLP Reminds MDCA, PTVCA, CBLI, and WIFI Shareholders About Its Ongoing Investigations PRNewswireApr 09, 2021
SHAREHOLDER ALERT: WeissLaw LLP Reminds MDCA, FFG, PTVCA, and CBLI Shareholders About Its Ongoing Investigations PRNewswireApr 02, 2021
SHAREHOLDER ALERT: WeissLaw LLP Reminds FFG, PTVCA, NTWN and CBLI Shareholders About Its Ongoing Investigations PRNewswireMar 26, 2021
SHAREHOLDER ALERT: WeissLaw LLP Reminds TLRY, CBLI, AKER and OBLN Shareholders About Its Ongoing Investigations PRNewswireMar 19, 2021
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTWN, TLRY, CBLI, and AKER Shareholders About Its Ongoing Investigations PRNewswireMar 12, 2021
INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - PAND, PRAH, AEGN, PTVCA, CRHM, CBLI, AKER PRNewswireFeb 25, 2021
Cleveland BioLabs, Inc. Announces Closing of $14 Million Registered Direct Offering of Common Stock ACCESSWIREFeb 23, 2021
Cleveland BioLabs, Inc. Announces $14 Million Registered Direct Offering of Common Stock ACCESSWIREFeb 19, 2021
Cleveland BioLabs, Inc. Files Registration Statement on Form S-4 for Proposed Merger with Cytocom Inc. PRNewswireFeb 17, 2021
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Cleveland Bio files Form S-4 for Cytocom merger, shares up 27% Seeking AlphaFeb 18, 2021
ICON partners with Cytocom in a Phase 3 trial for Crohn's disease Seeking AlphaFeb 16, 2021
LOGI, PE among premarket gainers Seeking AlphaOct 20, 2020
24 Stocks Moving in Tuesday's Pre-Market Session TalkMarketsJan 28, 2020
Stock Charts To Watch - Monday, Jan. 27 TalkMarketsJan 27, 2020
A History Of Coronavirus Outbreaks And The Stock Market TalkMarketsJan 22, 2020
Cleveland BioLabs reports Q3 results Seeking AlphaNov 14, 2019
Cleveland BioLabs: Another Year - Only Cash Burn To Show Seeking AlphaNov 12, 2019
Cleveland BioLabs reports Q2 results Seeking AlphaAug 14, 2019
Companies In The Healthcare Sector To Consider/Avoid Taking Into Account Patent Activity Seeking AlphaAug 07, 2019
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Powered by StockSnips

66.07% Positive

Earnings View Earnings

Q4 2020	EST	Actual	Surprise
EPS:	Expected 2021-03-22
Rev:	Expected 2021-03-22

Q1 2021	EST	Actual	Surprise
EPS:	Expected 2021-06-01
Rev:	Expected 2021-06-01

Start Investing

The Best Online Stock Trading Brokers

Best Free Stock Trading Brokers

Best Forex Brokers

Best Futures Brokers

How to Invest in Real Estate

Best Day Trading Courses